As the virulence of any new emergent variant cannot be reliably predicted, rapid response measures may be required should there be substantial changes in population immunity against the dominant circulating variant, including any new variant of concern. JCVI will keep the epidemiology of COVID-19 under review and will provide advice for a surge response, as required.